National Bank of Canada FI Has $8.59 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

National Bank of Canada FI raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 9,419.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 93,384 shares of the medical device company’s stock after acquiring an additional 92,403 shares during the period. National Bank of Canada FI’s holdings in Cooper Companies were worth $8,585,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of COO. Fulton Bank N.A. grew its position in Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after purchasing an additional 109 shares in the last quarter. Torray Investment Partners LLC grew its holdings in shares of Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. increased its stake in shares of Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after acquiring an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after acquiring an additional 136 shares in the last quarter. Finally, Greenleaf Trust boosted its position in Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup cut their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus cut their price target on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Trading Down 5.6 %

Shares of NASDAQ:COO opened at $73.77 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock’s 50-day moving average is $87.76 and its 200-day moving average is $96.24. The company has a market cap of $14.75 billion, a P/E ratio of 37.83, a P/E/G ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a 52-week low of $73.34 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.